Accurate prognosis prediction is important for treatment planning in lung cancer, but deep learning-driven survival modelling is often limited by the scarcity of curated imaging cohorts with reliable outcome data. This study evaluates whether representations from a domain-specific foundation model can be used for multimodal survival prediction in data-constrained clinical settings.
arXiv:2607. 01001v1 Announce Type: cross Abstract: Radiomics is the established approach for CT-based lung cancer phenotyping, yet comparisons with foundation models rarely isolate contributions of feature extractor, classification head, and segmentation choice, or test cross-cohort robustness.
By Nils Neukirch, Martin Maurer, Nils Strodthoff
The paper introduces a multimodal dataset for survival prediction in resected pancreatic ductal adenocarcinoma, comprising 302 patients, 446 H&E whole-slide images, clinicopathological variables, targeted sequencing data for 154 patients, and overall survival outcomes. The authors evaluated fourteen survival‑prediction models, finding that a Ridge Cox regression on numeric clinicopathological variables achieved the highest concordance (≈0.65), while multimodal fusion of image and molecular data reached 0.619. These benchmarks provide a foundation for future research and external validation using this pancreas‑specific dataset.
By Anh-Tien Nguyen, Mawuko Tettey, Jacqueline Michelle Metsch, Teresa Zimmer, Niklas Ullrich, Mario Duker, Sandra Rungeling, Kirsten Reuter-Jessen, Tessa Rosenthal, Lena-Christin Conradi, Michael Ghadimi, Alexander Konig, Elisabeth Hessmann, Volker Ellenrieder, Philipp Strobel, Hanibal Bohnenberger, Anne-Christin Hauschild
arXiv:2608.24688v1 Announce Type: new
Abstract: Precision oncology necessitates a longitudinal model of patient state that captures cancer evolution and treatment over time, integrating multimodal ob...
By Eugene Vorontsov, Yi Kan Wang, Alican Bozkurt, Adam Casson, Ludmila Tydlitatova, Michal Zelechowski, Ezra E. W. Cohen, Jyoti D. Patel, Max Banaszak, Caitlin McWilliams, Shane Colley, Kate Sasser, Ryan Fukushima, Eric Lefkofsky, Razik Yousfi, Siqi Liu
arXiv:2512.08029v4 Announce Type: replace
Abstract: Clinical decision-making in oncology requires forecasting how disease evolves under treatment, yet most AI systems remain static predictors that ca...
By Tianxingjian Ding, Yuanhao Zou, Chen Chen, Mubarak Shah, Yu Tian
arXiv:2608.21571v1 Announce Type: new
Abstract: Lung cancer remains a leading cause of cancer-related mortality worldwide, and early diagnosis is critical for improving survival. However, early-stage...
By Olivera Kotevska, Ian Goethert, Michael McGee, Maria Mahbub, Sean R. Wilkinson, Rowena Yip, Myvizhi Esai Selvan, Zeynep H. Gumus, Claudia Henschke, Robert J. Klein, Providencia Morales, Samuel M Aguayo, Ioana Danciu, Mayanka Chandrashekar
arXiv:2609.09477v1 Announce Type: new
Abstract: Delineating lung tumours on computed tomography (CT) takes a considerable share of the time spent on radiotherapy planning, and a contour proposed by a...
By Yi Luo, Yike Guo, Wenxuan Li, Zongwei Zhou, Rui Zhang, Kai Ding
FedHisto-PAST v2 is a parameter‑efficient, stain‑aware federated learning framework for cross‑site lung histopathology classification, combining a frozen HIBOU‑B foundation model with techniques such as paired‑view prediction, feature consistency, prototype learning, and adaptive aggregation. In a five‑client, non‑IID simulation and an exploratory LungHist700 cohort, the method achieved a Macro‑F1 of 0.7286 and a balanced accuracy of 0.7305, with the prediction‑level consistency component providing the most clear independent benefit. The framework updated only about 1.25% of the model parameters, demonstrating efficient adaptation while acknowledging limitations in privacy guarantees and clinical validation.
By Muhammad Muhtasim Shahriar, M. M. Golam Hafiz, Saad Aloteibi, Mohammad Ali Moni
The paper presents a newly curated, multi-center, multi-modal, and longitudinal lung cancer dataset comprising 1,365 patients with whole-slide images, CT scans, PET scans, structured clinical data, transcriptomics, and follow-up information. The dataset features substantial, non-uniform missingness across modalities, making it ideal for evaluating robust multi-modal fusion strategies. Benchmarks on 12‑month overall survival, disease‑specific survival, and longitudinal hazard prediction demonstrate that integrating complementary modalities consistently outperforms uni-modal approaches, even under severe missing data.
By Rita Cordeiro Mendes, Maria Rita Fonseca Verdelho, Carlos Santiago, Catarina Barata
CFB-GBM v2.0 is an expanded longitudinal dataset of 264 glioblastoma patients, providing complete Gross Tumour Volume (GTV) delineations across all timepoints and derived volumetric RANO 2.0 response labels. The dataset includes brain masks, pre‑computed radiomic features, and WHO classification guidelines, all validated by radiation oncologists. It is publicly available on TCIA for use in computational methods for treatment response prediction and disease progression modeling.
arXiv:2608. 09721v1 Announce Type: new Abstract: Lung cancer remains one of the leading causes of cancer- related mortality worldwide.
By Mona Furukawa, Sai Hyne, Daniel R. McGowan, Bart{\l}omiej W. Papie\.z
arXiv:2609.22281v1 Announce Type: new
Abstract: Foundation models have recently demonstrated strong capabilities across a wide range of medical imaging tasks. However, their performance in structured...
By Benjamin Renoust, Pierre Baudot, Tiffany Foriel, Yousra Haddou, Charles Voyton, Pierre-Henri Siot, Ezequiel Geremia, Danny Francis, Jean-Christophe Brisset, Val\'erie Bourd\`es, Sylvain Bodard, Benoit Huet